ArticleThe Journal of international medical research2024

Risk of COVID-19 infection in patients with NSCLC receiving EGFR-TKI targeted therapy during the first wave in China.

Peng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.